Vical to Provide Company Update at BIO Investor Forum Conference

SAN DIEGO, Oct. 13, 2017 (GLOBE NEWSWIRE) — Vical Incorporated (Nasdaq:VICL) today announced that the company will provide an overview of its technologies, development programs, and outlook at 11:30 a.m. PT on Wednesday, October 18, at the BIO Investor Forum Conference (San Francisco – October 17-18).  A webcast of the company’s presentation will be available live through the Events & Presentations page in the Investors section of the Vical website at

About Vical
Vical develops biopharmaceutical products for the prevention and treatment of chronic or life-threatening infectious diseases, based on its patented DNA delivery technologies and other therapeutic approaches. Additional information on Vical is available at

Tony Ramos
(858) 646-1127